Stoke Therapeutics, Inc. (STOK)
34.23
+0.08
(+0.23%)
USD |
NASDAQ |
Dec 11, 13:35
Stoke Therapeutics Market Cap: 1.955B for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 25.88B |
| Janux Therapeutics, Inc. | 922.07M |
| Insmed, Inc. | 41.37B |
| Sarepta Therapeutics, Inc. | 2.272B |
| Aldeyra Therapeutics, Inc. | 285.77M |
Market Cap Related Metrics
| PE Ratio | 51.87 |
| PS Ratio | 9.713 |
| Price to Book Value | 6.346 |
| Price to Free Cash Flow | 38.14 |
| Price | 34.23 |
| Earnings Yield | 1.93% |
| Operating PE Ratio | 73.44 |
| Normalized PE Ratio | 51.87 |